Type
Internal restructuring
Country
France
Region
Location of affected unit(s)
Lyon, Villefrance-sur-Saône, Marle-sur-Serre, Trèbes, Gaillard
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals

246 jobs
Number of planned job losses
Job loss
94 jobs
Number of planned job creations
Job creation
Announcement Date
21 October 2024
Employment effect (start)
21 October 2024
Foreseen end date

Description

Bayer France, part of the German Bayer Group, a multinational pharmaceutical and biotechnology company, is cutting a net total of 152 jobs. This move is part of a broader global plan aimed at reducing costs and bureaucracy, which includes 400 job cuts worldwide, with 246 in France and 94 new positions being created.

Voluntary departures will occur until around June 2025, followed by layoffs. The cuts notably impact all sectors, especially factories in Villefranche-sur-Saône, Marle-sur-Serre, Trèbes, and a research centre in Gaillard. The group's interunion comprised of the CFDT, the CGT, and FO, raised criticism over the global plan's implementation in France, which seems to only affect operational workers, instead of management like in Germany. They have currently refused to sign a preliminary agreement.

In 2023, Bayer employed 99,723 people globally. As of 2022, Bayer workforce in France was of 2 ,962.The company has undergone several internal restructurings, recorded in the European Restructuring Monitor database.


Sources

Citation

Eurofound (2024), Bayer France, Internal restructuring in France, factsheet number 201799, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/201799.